Journal of Cancer Research and Immuno-Oncology

Show Articles
Journal Properties
  • Number of Articles
    25
  • Abbreviation
    J Cancer Res Immunooncol
  • e-ISSN
    2684-1266
  • Publisher
    Longdom Group
  • Indian UGC
  • DOAJ (latest)
Description
The Journal of Cancer Research and Immuno-Oncology is an open-access journal dedicated to advancing the understanding and treatment of cancer through innovative research in cancer biology, immunology, and immuno-oncology. The journal publishes high-quality articles covering various aspects of cancer research, including basic science, translational research, clinical trials, and novel therapeutic strategies. Key areas of focus include tumor immunology, cancer immunotherapy, molecular mechanisms of cancer, and development of novel cancer biomarkers. The journal provides a platform for researchers, clinicians, and scientists to share their latest findings and contribute to the development of more effective cancer therapies. Indexed in major databases, the journal ensures broad visibility and accessibility of published research. The target audience includes oncologists, immunologists, cancer researchers, and healthcare professionals. By publishing high-impact research and fostering collaboration, the Journal of Cancer Research and Immuno-Oncology aims to accelerate progress in the fight against cancer and improve patient outcomes. The journal welcomes submissions that address critical challenges in cancer research and contribute to the development of innovative and personalized cancer therapies.